Glenmark Pharmaceuticals Inc., USA Launches Olanzapine for Injection
Glenmark Pharmaceuticals Inc., USA (Glenmark) has announced the official launch of Olanzapine for Injection, 10mg/vial, available as a Single-Dose Vial.
The newly launched product is bioequivalent...
GSK-partnered Hansoh Pharma reports positive Phase III lung cancer data.
GSK plc shared an announcement from its licensor, HansohPharmaceutical Group Co., Ltd., confirming that the pivotal phase III ARTEMIS-008 trial evaluating risvutatug rezetecan(Ris-Rez) met its primary endpoint...
Health Ministry Completes Nationwide Training Program for Ayushman Arogya Mandir Staff
The Union Health Ministry has completed a two-day National Training of Trainers covering all five categories of primary healthcare staff at Ayushman ArogyaMandirs, hosted at the...
Dr. Reddy’s Issues Immediate Recall of Specific Semaglutide Injection Batches
Dr. Reddy’s Laboratories Ltd. has announced a temporary delay in the commercial supply of semaglutide products marketed in India. The suspension follows a routine assessment revealing that...
Army Hospital R&R Performs First Robotic Stereotactic Brain Stem Biopsy
In a landmark achievement for military medicine, the Neurosurgery Department at the Army Hospital Research & Referral (R&R) has successfully performed the first-ever robotic...
Vertex to Acquire Crinetics Pharmaceuticals for $10.0 Billion, Expanding Rare Endocrine Disease Portfolio
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. announced a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in...
